193 related articles for article (PubMed ID: 19346644)
21. Molecular genetic evidence for subtypes of oligoastrocytomas.
Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics.
Ruff MW; Uhm J
Curr Treat Options Oncol; 2018 Oct; 19(12):61. PubMed ID: 30361986
[TBL] [Abstract][Full Text] [Related]
23. Impact of morphology and biology on the prognosis of patients with gliomas.
Gudinaviciene I; Pranys D; Juozaityte E
Medicina (Kaunas); 2004; 40(2):112-20. PubMed ID: 15007269
[TBL] [Abstract][Full Text] [Related]
24. [Advances in adults' gliomas biology, imaging and treatment].
Ducray F; Dutertre G; Ricard D; Gontier E; Idbaih A; Massard C
Bull Cancer; 2010 Jan; 97(1):17-36. PubMed ID: 20028650
[TBL] [Abstract][Full Text] [Related]
25. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
Ivliev AE; 't Hoen PA; Sergeeva MG
Cancer Res; 2010 Dec; 70(24):10060-70. PubMed ID: 21159630
[TBL] [Abstract][Full Text] [Related]
26. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma.
Ritland SR; Ganju V; Jenkins RB
Genes Chromosomes Cancer; 1995 Apr; 12(4):277-82. PubMed ID: 7539282
[TBL] [Abstract][Full Text] [Related]
27. [Occurrence and molecular pathology of low grade gliomas].
Murnyák B; Csonka T; Klekner A; Hortobágyi T
Ideggyogy Sz; 2013 Sep; 66(9-10):305-11. PubMed ID: 24358685
[TBL] [Abstract][Full Text] [Related]
28. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations.
Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T
J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883
[TBL] [Abstract][Full Text] [Related]
29. Updates in Pediatric Glioma Pathology.
Hakar MH; Wood MD
Surg Pathol Clin; 2020 Dec; 13(4):801-816. PubMed ID: 33183734
[TBL] [Abstract][Full Text] [Related]
30. Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.
Caskey LS; Fuller GN; Bruner JM; Yung WK; Sawaya RE; Holland EC; Zhang W
Histol Histopathol; 2000 Jul; 15(3):971-81. PubMed ID: 10963139
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
Tabouret E; Nguyen AT; Dehais C; Carpentier C; Ducray F; Idbaih A; Mokhtari K; Jouvet A; Uro-Coste E; Colin C; Chinot O; Loiseau H; Moyal E; Maurage CA; Polivka M; Lechapt-Zalcman E; Desenclos C; Meyronet D; Delattre JY; Figarella-Branger D;
Acta Neuropathol; 2016 Oct; 132(4):625-34. PubMed ID: 27573687
[TBL] [Abstract][Full Text] [Related]
32. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
Macaulay RJ
Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
[TBL] [Abstract][Full Text] [Related]
33. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
Smith JS; Alderete B; Minn Y; Borell TJ; Perry A; Mohapatra G; Hosek SM; Kimmel D; O'Fallon J; Yates A; Feuerstein BG; Burger PC; Scheithauer BW; Jenkins RB
Oncogene; 1999 Jul; 18(28):4144-52. PubMed ID: 10435596
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
[TBL] [Abstract][Full Text] [Related]
35. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
36. [Classification and grading of glial tumors].
Kros JM
Ned Tijdschr Geneeskd; 1996 Feb; 140(6):292-7. PubMed ID: 8720701
[No Abstract] [Full Text] [Related]
37. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
[TBL] [Abstract][Full Text] [Related]
38. Clinical impact of molecular biomarkers in gliomas.
Siegal T
J Clin Neurosci; 2015 Mar; 22(3):437-44. PubMed ID: 25533211
[TBL] [Abstract][Full Text] [Related]
39. Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas.
Ferguson SD; Zhou S; Huse JT; de Groot JF; Xiu J; Subramaniam DS; Mehta S; Gatalica Z; Swensen J; Sanai N; Spetzler D; Heimberger AB
J Neuropathol Exp Neurol; 2018 Jun; 77(6):437-442. PubMed ID: 29718398
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructural cytopathology of human cerebral gliomas.
Hossmann KA; Wechsler W
Oncology; 1971; 25(5):455-80. PubMed ID: 4335473
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]